The role of screening in the management of skin cancer

Current Opinion in Oncology

Volumn 11, Issue 2, 1999, Pages 123-128

  Wolfe, Jonathan T ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER SCREENING; HUMAN; MELANOMA; PATIENT EDUCATION; PATIENT SELECTION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SKIN CANCER; UNITED STATES;

HUMANS; MASS SCREENING; MELANOMA; SKIN NEOPLASMS;

EID: 0032992822     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199903000-00008     Document Type: Review

References (64)

1. Johnson T, Dolan M, Hamilton T, Lu M, Swanson N, Lowe L: Clinical and histologic trends of melanoma. J Am Acad Dermatol 1998, 5:681-686. This article is an intriguing review with up-to-date statistical data for melanoma in 1998.
2. Friedman RJ, Rigel DS, Silverman M: Malignant melanoma in the 1990's. The continued importance of early detection and the role of physician examination and self examination of the skin. CA Cancer J Clin 1991, 41:201-206.
3. Koh HK: Cutaneous melanoma. N Engl J Med 1991, 325:171-182.
4. Roush GC, Berwick M, Koh HK, MacKie RM: Screening for melanoma. In Cutaneous Melanoma, edn 2. Edited by Balch CM, Houghton AN, Milton GW. Philadelphia: JB Lippincott; 1992.
5. United States Preventive Services Task Force: Guide to Clinical Preventive Services, edn 2. Baltimore: Williams & Wilkins; 1996.
6. Gloster H, Brodland D: The epidemiology of skin cancer. Dermatol Surg 1996, 3:217-221.
7. Miller A, Chamberlain J, Day NE, Hakama M, Miller AB: Report on a workshop of the UICC project on evaluation of screening for cancer. Int J Cancer 1990, 46:761-769.
8. Miller AB: General principles of evaluation of screening. In: Screening for cancer. Edited by Miller AB. Orlando, FL: Academic Press; 1985:3-24.
9. Koh HK, Geller A, Miller DR, Lew RA: Early detection of melanoma: an ounce of prevention may be a ton of work. J Am Acad Dermatol 1993, 28:645-647.
10. Berwick M, Bewgg CG, Fine JA, Rousch GC, Barnhill RL: Screening for cutaneous melanoma by skin self examination. J Natl Cancer Inst 1996, 88:17-23.
11. Albert VA, Koh HK, Geller AC, Miller DR, Prout MN, Lew RA: Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J Am Acad Dermatol 1990, 23:308-310.
12. Temoshok L, Heller BW, Sagebiel RW, Blois MS, Sweet DM, DiClemente RI, Gold ML: The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J Psychosom Res 1985, 29:139-153.
13. Goldsmith L, Koh HK, Bewerse B, Reilly B, Wyatt SW, Bergfeld WD, et al.: Complete proceedings from the conference to develop a national skin cancer agenda. American Academy of Dermatology and Centers for Disease Control and Prevention. April 8-10, 1995. J Am Acad Dermatol 1996, 35:748-756.
14. Miller DR, Geller AC, Wyatt SW, Halpern A, Howell JB, Cockerell C, et al.: Melanoma awareness and self examination practices: results from a national survey of Americans. J Am Acad Dermatol 1996, 34:962-970. This is an excellent study which reviews Americans' opinions regarding self-examinations.
15. Rhodes AR, Weinstock MA, Fitzpatrick TB, Mihm MC Jr, Sober AJ: Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA 1987, 258:3146-3154.
16. Geller AC, Koh HK, Miller DR, et al.: Death rates of malignant melanoma among white men-United States 1973-1988. MMWR Morbid Mortal Weekly Rep 1992, 41:20-21.
17. Wagner DK: Patterns of melanoma deaths in the United States. In Trends in cancer mortality in industrial countries. Edited by Davis DL, Hoel D. New York: New York Academy of Sciences; 1990, 609:252.
18. Hersey P, Sillar RW, Howe CG, Burton RC, Darbar SV, Foster HM, et al.: Factors related to the presentation of patients with thick primary melanomas. Med J Aust 1991, 154:583-587.
19. Geller AC, Miller DR, Lew RA, et al.: Cutaneous melanoma: another cancer that disproportionately affects the socioeconomically disadvantaged. Am J Public Health 1996,86:538-543.
20. Vasen HFA, Bergman W, VanHaeringen A, Scheffer E, van Slooten EA: The familial dysplastic nevus syndrome: natural history and the impact of screening on prognosis. A study of nine families in the Netherlands. Eur J Cancer Clin Oncol 1989, 25:337-341.
21. Masri GD, Clark WH Jr, Guerry D IV, Halpern A, Thompson CJ, Elder DE, et al.: Screening and surveillance of patients at high risk for malignant melanoma results in detection of earlier disease. J Am Acad Dermatol 1990, 22:1042-1047.
22. Richert SM, D'Amico F, Rhodes AR: Cutaneous melanoma: patient surveillance and tumor progression. J Am Acad Dermatol 1998, 39:571-577. This study details the need for close observation of individuals at high-risk of developing skin cancer.
23. MacKie RM, Mc Henry P, Hole D: Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high risk groups. Lancet 1993, 341:1618-1620.
24. Rigel DS, Rivers JK, Kopf AW, Friedman RJ, Vinokur AF, Heilman ER, Levenstein M: Dysplastic nevi: markers for increased risk for melanoma. Cancer 1989, 63:386-393.
25. Tucker MA, Crutcher WA, Harge P, Sagebiel RW: Familial and cutaneous features of dysplastic nevi: a case control study. J Am Acad Dermatol 1993, 28:558-564.
26. Kang W, Barnhill RL, Hihm MC, Fitzpatrick TB, Sober AJ: Melanoma risk in individuals with clinically atypical nevi. Arch Dermatol 1994, 130:999-1001.
27. Marghoob AA, Kopf AW, Rigel DS, Bart RS, Friedman RJ, Yadav S, et al.: Risk of cutaneous malignant melanoma in patients with "classic" atypcial mole syndrome. Arch Dermatol 1994, 130:993-998.
28. Schneider JS, Moore DH, Sagebiel RW: Risk factors for melanoma incidence in prospective follow up. The importance of atypical nevi. Arch Dermatol 1994, 130:1002-1007.
29. Hoffman K, Dirschka T, Schatz H, Segerling M, Tiemann T, Hoffmann A, Altmeyer P: A local education campaign on early diagnosis of malignant melanoma. Eur J Epidemiol 1993, 9:591-596.
30. Elwood JM: Screening and early diagnosis for melanoma in Australia and New Zealand. In Cancer Screening. Edited by Miller AAB, Chaberlain J, Day NE, et al. Cambridge: Cambridge University Press, 1991:243.
31. Krol S, Keijser MT, Van Der Rhee HJ, Welvaart K: Screening for skin cancer in the Netherlands. Acta Derm Venereol 1991, 71:317-321.
32. Brandberg Y, Bolund C, Michelson H, Mansson-Brahme E, Ringborg U, Sjoden PO: Psychological reactions in public melanoma screening. Eur J Cancer 1993, 29A:860-863.
33. Koh HK, Norton LA, Geller AC, Sun T, Rlgel DS, Miller DR, et al.: Evaluation of the American Academy of Dermatology's national skin cancer early detection and screening program. J Am Aced Dermatol 1996, 34:971-978.
34. Koh HK, Lew RA, Prout MN: Screening for melanoma/skin cancer: theoretic and practical considerations. J Am Acad Dermatol 1989, 20:159-172.
35. Koh HK, Geller AC, Miller DR, Caruso A, Gage I, Lew RA: Who is being screened for melanoma/skin cancer? Characteristics of persons screened in Massachusetts. J Am Acad Dermatol 1991, 24:271-277.
36. Weinstock MA: Prevalence of the early warning signs of melanoma among participants in the 1989 Rhode Island skin cancer screening. J Am Acad Dermatol 1990, 23:516-518.
37. Leffell DJ, Berwick M, Bolognia J: The effect of pre-education on patient compliance with full body examination in a public skin cancer screening. J Dermatol Surg Oncol 1993, 19:600-604.
38. Koh HK, Caruso A, Gage I, Geller AC, Prout MN, White H, et al.: Evaluation of melanoma/skin cancer screening in Massachusetts. Cancer 1990, 65:375-379.
39. Sober AJ: Digital epiluminescence microscopy in the evaluation of pigmented lesions: a brief review. Semin Surg Oncol 1993, 9:198-210.
40. Kopf AW, Mintzis M, Bart RS: Diagnostic accuracy in malignant melanoma. Arch Dermatol 1975, 111:1291-1292.
41. Grin CM, Kopf AW, Welkovich B, Bart RS, Levenstein MJ: Accuracy in the clinical diagnosis of malignant melanoma. Arch Dermatol 1990, 128:763-766.
42. Rampen FHJ, Rumke P: Referral pattern and accuracy of clinical diagnosis of cutaneous melanoma. Acta Derm Venereol 1988, 68:61-64.
43. Healsmith MF, Bourke JF, Osborne JE: An evaluation of the revised seven point checklist for the early diagnosis of cutaneous malignant melanoma. Br J Dermatol 1994, 130:48-50.
44. Little P, Keefe M, White J: Self screening for risk of melanoma: validity of self mole counting by patients in a single general practice. Br Med J 1995, 310:912-916.
45. Lawson DD, Moore DH, Schneider JS, Sagebiel RW: Nevus counting as a risk factor for melanoma: comparison of self count with count by physician. J Am Acad Dermatol 1994, 31:438-444.
46. Byles JE, Hennrikus D, Sanson-Fisher R, Hersey P: Reliability of naevus counts in identifying individuals at high risk of malignant melanoma. Br J Dermatol 1994, 130:51-56.
47. Gruber SB, Roush GC, Barnhill RL: Sensitivity and specificity of self examination for cutaneous malignant melanoma and risk factors. Am J Prev Med 1993, 9:50-53.
48. Girgis A, Campbell EM, Redman S, Sanson-Fisher RW: Screening for melanoma: a community survey of prevalence and predictors. Med J Aust 1991, 154:338-343.
49. Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MB, Lew RA: Who discovers melanoma? Patterns from a population based survey. J Am Acad Dermatol 1992, 26:914-919.
50. Lee G, Massa MC, Welyksy S, Choo J, Greaney V: Yield from total skin examination and effectiveness of skin cancer awareness program. Findings in 874 new dermatology patients. Cancer 1991, 67:202-205.
51. Goldsmith L, Koh HK, Bewerse B, et al.: Proceedings from the conference to develop a national skin cancer agenda. American Academy of Dermatology and Centers for Disease Control and Prevention. April 8-10, 1995. J Am Acad Dermatol 1996, 34:822-823. This is an important article for any skin cancer specialist.
52. MacKie RM, Hole D: Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J 1992, 304:1012-1015.
53. Theobald T, Marks R, Hill D, Dorevitch A: "Goodbye Sunshine." Effects of a television program about melanoma on beliefs, behavior, and melanoma thickness. J Am Acad Dermatol 1991, 25:717-723.
54. Krige JEJ, Isaacs S, Hudson DA, King HS, Strover RM, Johnson CA: Delay in the diagnosis of cutaneous melanoma: a prospective study in 250 patients. Cancer 1991, 68:2064-2068.
55. Miller DL, Weinstock MA: Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol 1994, 30:774-778.
56. Glass AG, Hoover RN: The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989, 262:2097-2100.
57. Paine SL, Cockburn J, Noy SM, Marks R: Early detection of skin cancer. Med J Aust 1994, 161:191-195.
58. NIH Consensus Conference: Diagnosis and treatment of early melanoma. JAMA 1992, 268:1314-1319.
59. Geller AC, Koh HK, Miller DR, Clapp RW, Mercer MB, Lew RA: Use of health services before the diagnosis of melanoma. Implications for early detection and screening. J Gen Intern Med 1992, 3:154-157.
60. Elwood JM, Gallagher RP: The first signs and symptoms of melanoma: A population based study. In Naevi and Melanoma: Incidence, Interrelationships, and Implications. Pigment Cell No. 9. Edited by Elwood JM. Basel: Karger; 1988:140.
61. Robinson JK, McGaphie WC: Skin cancer detection in a clinical practice examination with standardized patients. J Am Acad Dermatol 1996, 34:709-711.
62. Cristofolini M, Bianchi R, Boi S, DeCarli A, Micciolo R, Cristofolini P, Zumiani G: Effectiveness of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. J Dermatol Surg Oncol 1993, 19:117-120.
63. Koh HK, Geller AC, Miller DR, Lew RA: The early detection of and screening for melanoma. Cancer 1995, 75:674-683.
64. United States Preventive Services Task Force: Guide to Clinical Preventive Services, edn 2. Baltimore: Williams & Wilkins; 1996.